Citation: Df. Mobley et al., EFFECTS OF DOXAZOSIN IN PATIENTS WITH MILD, INTERMEDIATE, AND SEVERE BENIGN PROSTATIC HYPERPLASIA, Clinical therapeutics, 20(1), 1998, pp. 101-109
Authors:
KLONER RA
VETROVEC GW
MATERSON BJ
LEVENSTEIN M
Citation: Ra. Kloner et al., SAFETY OF LONG-ACTING DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS, The American journal of cardiology, 81(2), 1998, pp. 163-169
Authors:
PONS V
GREENSPAN D
LOZADANUR F
MCPHAIL L
GALLANT JE
TUNKEL A
JOHNSON CC
MCCARTY J
PANZER H
LEVENSTEIN M
BARRANCO A
GREEN S
Citation: V. Pons et al., OROPHARYNGEAL CANDIDIASIS IN PATIENTS WITH AIDS - RANDOMIZED COMPARISON OF FLUCONAZOLE VERSUS NYSTATIN ORAL SUSPENSIONS, Clinical infectious diseases, 24(6), 1997, pp. 1204-1207
Authors:
GLANZ M
KUPELNICK B
KUMASHIRO M
GARBER A
LEVENSTEIN M
ROSS SD
Citation: M. Glanz et al., EFFECTS OF ALPHA-BLOCKADE THERAPY ON GLUCOSE AND LIPID-METABOLISM IN HYPERTENSIVE PATIENTS WITH NIDDM - A METAANALYSIS, Diabetes, 46, 1997, pp. 1403-1403
Authors:
CAROW CE
LEVENSTEIN M
KAUFMANN SH
CHEN J
AMIN S
ROCKWELL P
WITTE L
BOROWITZ MJ
CIVIN CI
SMALL D
Citation: Ce. Carow et al., EXPRESSION OF THE HEMATOPOIETIC GROWTH-FACTOR RECEPTOR FLT3 (STK-1 FLK2) IN HUMAN LEUKEMIAS/, Blood, 87(3), 1996, pp. 1089-1096
Citation: D. Levy et al., PRINCIPAL RESULTS OF THE HYPERTENSION AND LIPID TRIAL (HALT) - A MULTICENTER STUDY OF DOXAZOSIN IN PATIENTS WITH HYPERTENSION, The American heart journal, 131(5), 1996, pp. 966-973
Citation: M. Levenstein, MASS-PRODUCTION CONQUERS THE POOL - FIRM ORGANIZATION AND THE NATURE OF COMPETITION IN THE 19TH-CENTURY, The Journal of economic history, 55(3), 1995, pp. 575-611
Citation: M. Levenstein, THE DETERMINANTS OF BARGAINING POWER IN AN INTERNATIONAL CARTEL - DOWAND THE DEUTSCHE BROMKONVENTION, 1908-1914, The Journal of economic history, 55(2), 1995, pp. 395-395
Citation: Tg. Pickering et al., NIGHTTIME DOSING OF DOXAZOSIN HAS PEAK EFFECT ON MORNING AMBULATORY BLOOD-PRESSURE - RESULTS OF THE HALT STUDY, American journal of hypertension, 7(9), 1994, pp. 844-847
Citation: Tg. Pickering et al., DIFFERENTIAL-EFFECTS OF DOXAZOSIN ON CLINIC AND AMBULATORY PRESSURE ACCORDING TO AGE, GENDER, AND PRESENCE OF WHITE COAT HYPERTENSION - RESULTS OF THE HALT STUDY, American journal of hypertension, 7(9), 1994, pp. 848-852
Authors:
SMALL D
LEVENSTEIN M
KIM E
CAROW C
AMIN S
ROCKWELL P
WITTE L
BURROW C
RATAJCZAK MZ
GEWIRTZ AM
CIVIN CI
Citation: D. Small et al., STK-1, THE HUMAN HOMOLOG OF FLK-2 FLT-3, IS SELECTIVELY EXPRESSED IN CD34(+) HUMAN BONE-MARROW CELLS AND IS INVOLVED IN THE PROLIFERATION OF EARLY PROGENITOR STEM-CELLS/, Proceedings of the National Academy of Sciences of the United Statesof America, 91(2), 1994, pp. 459-463
Authors:
CAROW CE
LEVENSTEIN M
KAUFMANN SH
CHEN J
AMIN S
ROCKWELL P
WITTE L
CIVIN CI
SMALL D
Citation: Ce. Carow et al., EXPRESSION OF THE HEMATOPOIETIC GROWTH-FACTOR RECEPTOR STK-1 (FLT3 FLK2), IN HUMAN ACUTE LEUKEMIAS/, Blood, 84(10), 1994, pp. 10000051-10000051
Authors:
SAFFORD M
LEVENSTEIN M
AMIN S
HAWKINS AL
GRIFFIN CA
CIVIN CI
SMALL D
Citation: M. Safford et al., JAK3, A MEMBER OF THE JAK FAMILY OF NONRECEPTOR TYROSINE KINASES, IS EXPRESSED IN THE STEM PROGENITOR-CELL FRACTION OF HUMAN BONE-MARROW, Blood, 84(10), 1994, pp. 10000122-10000122
Authors:
SMALL D
LEVENSTEIN M
KIM E
CAROW CE
AMIN S
RATAJCZAK M
GEWIRTZ AM
Citation: D. Small et al., STK-1, A HUMAN HOMOLOG OF FLK-2 FLT3, IS ABERRANTLY EXPRESSED IN HUMAN LEUKEMIAS AND MAY BE INVOLVED IN THE GROWTH AND OR DIFFERENTIATION OF HEMATOPOIETIC STEM PROGENITOR CELLS/, Blood, 82(10), 1993, pp. 10000325-10000325